Prove Patient Access, Win More Trials

The top question we get from sites is “how can I maximize my chances of selection?” Today, we’re unlocking a powerful new way to stand out: by showcasing patient access data to sponsors during feasibility using Inato’s AI patient pre-screening. 

Though sponsors have troves of data on site experience and past performance, they lack visibility into real-time, trial-specific data on which sites have the right patients. This often leads to an overreliance on large, well-established sites that seem less risky, rather than optimizing for sites where there’s real patient fit and need. Now, we’re turning that model on its head by unlocking previously unavailable, high-value patient access data at the site level.

Many sites are already using Inato’s AI patient pre-screening to quickly and easily find and enroll the right patients for their trials (reducing chart review times by up to 90%). Now, for the first time, sites can bring that data into feasibility. The new features enable sites to showcase verified patient access data to sponsors to prove fit and maximize their chances of selection, inside or outside of the Inato platform.  

‍
Why leverage Inato’s AI patient pre-screening during feasibility

• Stand out to sponsors: Sponsors crave verified, trial-specific patient access data. Now, you can demonstrate that you have the right patient population to perform on specific studies—for trials in the Inato platform or outside of it.  
• Boost your chances of selection: Historically, site selection has relied on enrollment estimates. Not anymore. Give your team an edge—and sponsors the confidence to select—with verified data on patient eligibility.‍
• Hit the ground running: Once selected for trials, focus solely on the most relevant patients to maximize enrollment.

‍

‍
How it works

You need to be using Inato’s AI patient pre-screening tool to take advantage of these new capabilities. Our platform determines verified patient access by comparing your patient records (uploaded or pulled from your EHR) against the inclusion and exclusion criteria for the trial at hand. If you’re not using AI patient pre-screening yet—or if you are, but want to set up an EHR integration to make the process faster, easier, and more thorough—get in touch with our team here. 

Once you’re up and running, you’re just a few clicks away from putting your best foot forward with sponsors.

• For trials in Inato: You’ll be prompted to prove patient access using Inato patient pre-screening. Follow the cues and within a few minutes Inato will populate data on how many potentially eligible patients you have, based on inclusion and exclusion criteria. This data will be displayed to sponsors when you apply, alongside information like your team experience, accessibility features, community outreach programs, capabilities, and more.

• For trials outside of Inato: Input the NCTID (or your own trial and criteria), follow the cues in the platform, and get a downloadable, sponsor-ready report on how many potentially eligible patients you have for the trial in minutes.